Cognitive Load Assessment of Helicopter Pilots in Training (ECCOLicoF)

February 12, 2025 updated by: Direction Centrale du Service de Santé des Armées

ÉVALUATION DE LA CHARGE COGNITIVE DES PILOTES D'HÉLICOPTÈRES EN FORMATION "ECCOLicoF"

The aim of this study is to identify the effect of the increase of the situation demands, with or without a thread, on military helicopter pilot's cognitive load, depending on their skills acquisition (at the beginning, midway and end of training course). This study is carried out on a simulator, in virtual reality and allows to identify the moments of cognitive load enhancement and the associated indicators such as subjective, physiological and behavioural indicators. Recommendations will be done to go towards an individualization of the lessons during the pilots education, by anticipating an overload which has a deleterious effect on learning.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

32

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Military helicopter pilots trainees

Description

Inclusion Criteria:

  • Being a trainee at the Instructional center of helicopter crews
  • Being more than 18 years old
  • Being insured under the French social security system
  • Having the bases to pilot helicopters
  • Having signed the non-opposition form

Exclusion Criteria:

  • Being minor or an incapacitated adult
  • Being in a motor handicap situation
  • Having a cardiac pathology
  • Having a visual pathology that is uncorrected by glasses or lens
  • Having a bad audition
  • Having a psychiatric disorder, a neurologic or organic disorder requiring a medical treatment
  • Taking psychotropics
  • Drinking more than 28 units of alcohol per week
  • Being epileptic

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective level of cognitive load
Time Frame: It is completed during 5 minutes after each of the six scenarios
The NASA-TLX questionnaire is used to assess the subjective level of cognitive load
It is completed during 5 minutes after each of the six scenarios

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Objective level of cognitive load
Time Frame: It is measured during each of the six scenarios lasting around 5 minutes
It is measures by physiological indicators ( cardiac activity and electroencephalogram) and behavioural indicators (tasks performance, ocular saccades and blinks)
It is measured during each of the six scenarios lasting around 5 minutes
Subjective level of anxiety
Time Frame: It is measured during 1 minute after each of the six scenarios
It is measured by a visual analogue scale
It is measured during 1 minute after each of the six scenarios
Objective level of anxiety
Time Frame: It is measured during each of the six scenarios lasting around 5 minutes
It is measured by the electrodermal activity
It is measured during each of the six scenarios lasting around 5 minutes
Subjective level of fatigue
Time Frame: It is measured during 1 minute before each of the six scenarios
It is measured by the Karolinska Sleepiness Scale
It is measured during 1 minute before each of the six scenarios

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Direction Centrale du Service de Santé des Armées

Investigators

  • Study Chair: Julie ALBENTOSA, IRBA, 1 place Valérie André, 91 223 Brétigny-sur-Orge cedex

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2028

Study Registration Dates

First Submitted

February 12, 2025

First Submitted That Met QC Criteria

February 12, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 12, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2023PBMD04
  • 2024-A01855-42 (Other Identifier: IDRCB)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Impairment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe